Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Oncol Res ; 13(4): 191-7, 2003.
Article in English | MEDLINE | ID: mdl-12659419

ABSTRACT

The novel 6-dialkylaminoalkylamino-3,3,12-trimethyl-3,12-dihydro-7H-pyrano[2,3-c]acridine-7-ones 5-11 and their benzo [b]pyrano[2,3-h]acridine-7-one counterparts 12-18 were prepared by treatment of acronycine (1) or benzo[b]acronycine (4) with an excess of the appropriate dialkylaminoalkylamine. In both series, the introduction of a dialkylaminoalkylamino side chain at position 6 resulted in a significant increase of the cytotoxic activity against L1210 cells when compared with the parent compounds bearing a methoxy group, accompanied with an increased potency to arrest cells in the G2 + M phases of the cell cycle.


Subject(s)
Acridines/chemical synthesis , Acridines/toxicity , Acronine/chemical synthesis , Acronine/toxicity , Acronine/analogs & derivatives , Animals , Cell Division/drug effects , Cell Division/physiology , Drug Screening Assays, Antitumor/methods , Mice , Solubility , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...